Divi's Labs posts PAT of Rs 358 crore in Q3; material consumption at 39% of sales
Divi's Laboratories' consolidated net profit for Q3 FY24 was Rs 358 crores as against a PAT of Rs 306 crore for Q3 FY23, thereby recording a growth of 17% YoY.
The companys total income in the third quarter rose by 7% to Rs 1950 crore from Rs 1821 crore posted in the same period last year.
Material consumption for this quarter came to be about 39% of sales revenue. It was 43% of sales revenue in the corresponding period last fiscal.
Profit before tax in Q3 FY24 stood at Rs 489 crore, up by 12% from Rs 435 crore in Q3 FY23.
On a standalone basis, the company has posted revenue and PAT of Rs 1,902 crore (up 5% YoY) and Rs 358 crore (up 15% YoY), respectively, in Q3 FY24.
Also Read
Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
The scrip shed 0.90% to end at Rs 3651 on the BSE on Friday.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 10 2024 | 2:20 PM IST